Kaplan–Meier curve analysis demonstrated that higher expression levels of the aforementioned 10 regulators, including TRMT6, TRMT61A, TRMT61B, TRMT10C, ALKBH1, ALKBH3, YTHDF1, YTHDF2, YTHDF3, and YTHDC1, correlated with poorer clinical outcomes for patients with HCC (p < 0.05, Fig. 1E–N). This evidence concerns the gene TRMT61B and hepatocellular carcinoma.